Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
Temporal Hierarchical Adaptive Texture CRF for Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI.
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
From the Cajal alumni Achúcarro and Río-Hortega to the rediscovery of never-resting microglia.
Silent aspiration and recovery from Dysphagia in a case of bickerstaff brainstem encephalitis.
Health related quality of life in patients recently diagnosed with multiple sclerosis.
Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis.
Astrogliosis During Acute and Chronic Cuprizone Demyelination and Implications for Remyelination.
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations.
Current status of chemokines in the adult CNS.
Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation.
Multiple sclerosis genetics.
Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.
The complex immunology of multiple sclerosis.
N-Cadherin Promotes Recruitment and Migration of Neural Progenitor Cells from the SVZ Neural Stem Cell Niche into Demyelinated Lesions.
Multiple Sclerosis: Current Knowledge and Future Outlook.
Need for the upcoming revision of the current diagnostic criteria for NMO - response to the letter from Zhou et al.
[Ultrahigh field MRI in context of neurological diseases.]
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab.
Pages
« first
‹ previous
…
383
384
385
386
387
388
389
390
391
…
next ›
last »